The cellular and humoral immunity assay in patients with complicated urolithiasis

Especially complicated, renal lithiasis contributes to the general inflammatory syndrome development that interferes with nonspecific, humoral and cellular immune system. The surgical treatment of nephrolithiasis is closely related to drug therapy of urinary infection, one of the reasons being the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceban, E, Banov, P, Galescu, A, Tanase, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2017
Materias:
Case Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304380/
https://www.ncbi.nlm.nih.gov/pubmed/28255384
_version_ 1782506874496614400
author Ceban, E
Banov, P
Galescu, A
Tanase, D
author_facet Ceban, E
Banov, P
Galescu, A
Tanase, D
author_sort Ceban, E
collection PubMed
description Especially complicated, renal lithiasis contributes to the general inflammatory syndrome development that interferes with nonspecific, humoral and cellular immune system. The surgical treatment of nephrolithiasis is closely related to drug therapy of urinary infection, one of the reasons being the reduction of the immune status. The work is performed by evaluating the immunological status preoperatively in 58 patients with complicated lithiasis. The analysis of the status in these patients demonstrated that complicated urolithiasis results in significant changes in the immune system, these changes being expressed at the cellular and humoral level of immunity.
format Online
Article
Text
id pubmed-5304380
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-53043802017-03-02 The cellular and humoral immunity assay in patients with complicated urolithiasis Ceban, E Banov, P Galescu, A Tanase, D J Med Life Case Presentations Especially complicated, renal lithiasis contributes to the general inflammatory syndrome development that interferes with nonspecific, humoral and cellular immune system. The surgical treatment of nephrolithiasis is closely related to drug therapy of urinary infection, one of the reasons being the reduction of the immune status. The work is performed by evaluating the immunological status preoperatively in 58 patients with complicated lithiasis. The analysis of the status in these patients demonstrated that complicated urolithiasis results in significant changes in the immune system, these changes being expressed at the cellular and humoral level of immunity. Carol Davila University Press 2017 /pmc/articles/PMC5304380/ /pubmed/28255384 Text en ©Carol Davila University Press This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Case Presentations
Ceban, E
Banov, P
Galescu, A
Tanase, D
The cellular and humoral immunity assay in patients with complicated urolithiasis
title The cellular and humoral immunity assay in patients with complicated urolithiasis
title_full The cellular and humoral immunity assay in patients with complicated urolithiasis
title_fullStr The cellular and humoral immunity assay in patients with complicated urolithiasis
title_full_unstemmed The cellular and humoral immunity assay in patients with complicated urolithiasis
title_short The cellular and humoral immunity assay in patients with complicated urolithiasis
title_sort cellular and humoral immunity assay in patients with complicated urolithiasis
topic Case Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304380/
https://www.ncbi.nlm.nih.gov/pubmed/28255384
work_keys_str_mv AT cebane thecellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT banovp thecellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT galescua thecellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT tanased thecellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT cebane cellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT banovp cellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT galescua cellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis
AT tanased cellularandhumoralimmunityassayinpatientswithcomplicatedurolithiasis

Ejemplares similares